Cargando…

Complementary Roles of Squamous Cell Carcinoma Antigen and (18)F-FDG PET/CT in Suspected Recurrence of Cervical Squamous Cell Cancer

Purpose: To assess the clinical value of FDG PET/CT and evaluate the complementary roles of serum squamous cell carcinoma antigen (SCCAg) and FDG PET/CT in the diagnosis of suspected recurrent of cervical squamous cell cancer. Methods: Serum SCCAg levels were retrospectively reviewed in patients pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Ying-Ying, Fan, Wei, Zhang, Xu, Liang, Pei-Yan, Lin, Xiao-Ping, Zhang, Ya-Rui, Li, Yuan-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317765/
https://www.ncbi.nlm.nih.gov/pubmed/25663947
http://dx.doi.org/10.7150/jca.10819
_version_ 1782355725667794944
author Hu, Ying-Ying
Fan, Wei
Zhang, Xu
Liang, Pei-Yan
Lin, Xiao-Ping
Zhang, Ya-Rui
Li, Yuan-Hua
author_facet Hu, Ying-Ying
Fan, Wei
Zhang, Xu
Liang, Pei-Yan
Lin, Xiao-Ping
Zhang, Ya-Rui
Li, Yuan-Hua
author_sort Hu, Ying-Ying
collection PubMed
description Purpose: To assess the clinical value of FDG PET/CT and evaluate the complementary roles of serum squamous cell carcinoma antigen (SCCAg) and FDG PET/CT in the diagnosis of suspected recurrent of cervical squamous cell cancer. Methods: Serum SCCAg levels were retrospectively reviewed in patients previously treated for cervical squamous cell carcinoma, who had suspected recurrence of cervical cancer and who had undergone FDG PET/CT scans. The clinical impact of elevated SCCAg (>1.5 ng/ml) and negative SCCAg (≤1.5 ng/ml) levels were analyzed based on the results of PET/CT and final diagnosis. Results: The overall patient-based sensitivity, specificity, accuracy, positive predictive value (PPV) and negative predictive value (NPV) of PET/CT for the detection of tumor recurrence or malignancy were 100% (86/86), 80.8% (21/26), 95.5% (107/112), 94.5% (86/91) and 100% (21/21), respectively. Of the 112 patients included in this study, recurrence or malignancy was detected by PET/CT in 62 of the 64 patients with elevated SCCAg, compared to 24 of the 48 patients with negative SCCAg levels. The overall patient-based PPV, NPV, sensitivity and accuracy of SCCAg for the detection of tumor recurrence or malignancy were 96.9% (62/64), 50% (24/48), 72.1% (62/86) and 76.8% (86/112), respectively. The five false-positive PET/CT results were all associated with patients with negative SCCAg levels. The PPV of positive PET/CT-associated elevated SCCAg for the detection of tumor recurrence or malignancy was 100% (62/62). The NPV of negative SCCAg-associated negative PET/CT was 100% (19/19). Conclusions: Serum SCCAg evaluation and FDG PET/CT imaging can be complementary techniques in cases of suspected recurrent cervical squamous cancer. Positive PET/CT with elevated SCCAg can predict recurrence. Although PET/CT cannot confidently be deferred due to a negative SCCAg test, the possibility of a false-positive PET/CT in those cases may have diagnostic importance.
format Online
Article
Text
id pubmed-4317765
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-43177652015-02-06 Complementary Roles of Squamous Cell Carcinoma Antigen and (18)F-FDG PET/CT in Suspected Recurrence of Cervical Squamous Cell Cancer Hu, Ying-Ying Fan, Wei Zhang, Xu Liang, Pei-Yan Lin, Xiao-Ping Zhang, Ya-Rui Li, Yuan-Hua J Cancer Research Paper Purpose: To assess the clinical value of FDG PET/CT and evaluate the complementary roles of serum squamous cell carcinoma antigen (SCCAg) and FDG PET/CT in the diagnosis of suspected recurrent of cervical squamous cell cancer. Methods: Serum SCCAg levels were retrospectively reviewed in patients previously treated for cervical squamous cell carcinoma, who had suspected recurrence of cervical cancer and who had undergone FDG PET/CT scans. The clinical impact of elevated SCCAg (>1.5 ng/ml) and negative SCCAg (≤1.5 ng/ml) levels were analyzed based on the results of PET/CT and final diagnosis. Results: The overall patient-based sensitivity, specificity, accuracy, positive predictive value (PPV) and negative predictive value (NPV) of PET/CT for the detection of tumor recurrence or malignancy were 100% (86/86), 80.8% (21/26), 95.5% (107/112), 94.5% (86/91) and 100% (21/21), respectively. Of the 112 patients included in this study, recurrence or malignancy was detected by PET/CT in 62 of the 64 patients with elevated SCCAg, compared to 24 of the 48 patients with negative SCCAg levels. The overall patient-based PPV, NPV, sensitivity and accuracy of SCCAg for the detection of tumor recurrence or malignancy were 96.9% (62/64), 50% (24/48), 72.1% (62/86) and 76.8% (86/112), respectively. The five false-positive PET/CT results were all associated with patients with negative SCCAg levels. The PPV of positive PET/CT-associated elevated SCCAg for the detection of tumor recurrence or malignancy was 100% (62/62). The NPV of negative SCCAg-associated negative PET/CT was 100% (19/19). Conclusions: Serum SCCAg evaluation and FDG PET/CT imaging can be complementary techniques in cases of suspected recurrent cervical squamous cancer. Positive PET/CT with elevated SCCAg can predict recurrence. Although PET/CT cannot confidently be deferred due to a negative SCCAg test, the possibility of a false-positive PET/CT in those cases may have diagnostic importance. Ivyspring International Publisher 2015-01-20 /pmc/articles/PMC4317765/ /pubmed/25663947 http://dx.doi.org/10.7150/jca.10819 Text en © 2015 Ivyspring International Publisher. Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. See http://ivyspring.com/terms for terms and conditions.
spellingShingle Research Paper
Hu, Ying-Ying
Fan, Wei
Zhang, Xu
Liang, Pei-Yan
Lin, Xiao-Ping
Zhang, Ya-Rui
Li, Yuan-Hua
Complementary Roles of Squamous Cell Carcinoma Antigen and (18)F-FDG PET/CT in Suspected Recurrence of Cervical Squamous Cell Cancer
title Complementary Roles of Squamous Cell Carcinoma Antigen and (18)F-FDG PET/CT in Suspected Recurrence of Cervical Squamous Cell Cancer
title_full Complementary Roles of Squamous Cell Carcinoma Antigen and (18)F-FDG PET/CT in Suspected Recurrence of Cervical Squamous Cell Cancer
title_fullStr Complementary Roles of Squamous Cell Carcinoma Antigen and (18)F-FDG PET/CT in Suspected Recurrence of Cervical Squamous Cell Cancer
title_full_unstemmed Complementary Roles of Squamous Cell Carcinoma Antigen and (18)F-FDG PET/CT in Suspected Recurrence of Cervical Squamous Cell Cancer
title_short Complementary Roles of Squamous Cell Carcinoma Antigen and (18)F-FDG PET/CT in Suspected Recurrence of Cervical Squamous Cell Cancer
title_sort complementary roles of squamous cell carcinoma antigen and (18)f-fdg pet/ct in suspected recurrence of cervical squamous cell cancer
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317765/
https://www.ncbi.nlm.nih.gov/pubmed/25663947
http://dx.doi.org/10.7150/jca.10819
work_keys_str_mv AT huyingying complementaryrolesofsquamouscellcarcinomaantigenand18ffdgpetctinsuspectedrecurrenceofcervicalsquamouscellcancer
AT fanwei complementaryrolesofsquamouscellcarcinomaantigenand18ffdgpetctinsuspectedrecurrenceofcervicalsquamouscellcancer
AT zhangxu complementaryrolesofsquamouscellcarcinomaantigenand18ffdgpetctinsuspectedrecurrenceofcervicalsquamouscellcancer
AT liangpeiyan complementaryrolesofsquamouscellcarcinomaantigenand18ffdgpetctinsuspectedrecurrenceofcervicalsquamouscellcancer
AT linxiaoping complementaryrolesofsquamouscellcarcinomaantigenand18ffdgpetctinsuspectedrecurrenceofcervicalsquamouscellcancer
AT zhangyarui complementaryrolesofsquamouscellcarcinomaantigenand18ffdgpetctinsuspectedrecurrenceofcervicalsquamouscellcancer
AT liyuanhua complementaryrolesofsquamouscellcarcinomaantigenand18ffdgpetctinsuspectedrecurrenceofcervicalsquamouscellcancer